These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10660504)

  • 1. Antimicrobial effects of lidocaine in bronchoalveolar lavage fluid.
    Olsen KM; Peddicord TE; Campbell GD; Rupp ME
    J Antimicrob Chemother; 2000 Feb; 45(2):217-9. PubMed ID: 10660504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of respiratory bacteria to lignocaine.
    Chandan SS; Faoagali J; Wainwright CE
    Pathology; 2005 Aug; 37(4):305-7. PubMed ID: 16194830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain.
    Escribano Montaner A; García de Lomas J; Villa Asensi JR; Asensio de la Cruz O; de la Serna Blázquez O; Santiago Burruchaga M; Mondéjar López P; Torrent Vernetta A; Feng Y; Van Dyke MK; Reyes J; Garcia-Corbeira P; Talarico CA;
    Eur J Pediatr; 2018 Feb; 177(2):181-192. PubMed ID: 29285648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM; Suter M; Borsos S
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Lee HY; Andalibi A; Webster P; Moon SK; Teufert K; Kang SH; Li JD; Nagura M; Ganz T; Lim DJ
    BMC Infect Dis; 2004 May; 4():12. PubMed ID: 15125783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children with acute otitis media in Japan from 2014 to 2017.
    Nagai K; Kimura O; Domon H; Maekawa T; Yonezawa D; Terao Y
    J Infect Chemother; 2019 Mar; 25(3):229-232. PubMed ID: 30279114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).
    Gales A; Sader H; Jones RN;
    Antimicrob Agents Chemother; 2001 May; 45(5):1463-6. PubMed ID: 11302811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases.
    Suzuki K; Fujisawa T; Nakashima M; Hamasaki R
    J Infect Chemother; 2005 Oct; 11(5):253-5. PubMed ID: 16258823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan.
    Lau YJ; Hsueh PR; Liu YC; Shyr JM; Huang WK; Teng LJ; Liu CY; Luh KT
    Microb Drug Resist; 2006; 12(2):130-5. PubMed ID: 16922631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
    Doern GV
    Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.
    Casellas JM; Gilardoni M; Tome G; Goldberg M; Ivanovic S; Orduna M; Dolmann A; Ascoli M; Ariza H; Montero JM
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():37-42. PubMed ID: 10404336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I; Robbins M; Viljoen L; Brown DF
    J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.
    Manninen R; Huovinen P; Nissinen A
    J Antimicrob Chemother; 1997 Sep; 40(3):387-92. PubMed ID: 9338492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program.
    Zhang Y; Zhang F; Wang H; Zhao C; Wang Z; Cao B; Du Y; Feng X; Hu Y; Hu B; Ji P; Liu Z; Liu Y; Liao W; Lu J; Sun H; Wang Z; Xu X; Xu X; Yang Q; Yu Y; Zhang R; Zhuo C
    J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.